214 related articles for article (PubMed ID: 25552740)
1. Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains.
Sotgiu G; Centis R; D'Ambrosio L; Castiglia P; Migliori GB
Eur Respir J; 2015 Jan; 45(1):287-9. PubMed ID: 25552740
[No Abstract] [Full Text] [Related]
2. Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains.
Weiss T; Schönfeld N; Otto-Knapp R; Bös L; Bettermann G; Mauch H; Bauer TT; Rüssmann H
Eur Respir J; 2015 Jan; 45(1):285-7. PubMed ID: 25552739
[No Abstract] [Full Text] [Related]
3. Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence.
Sotgiu G; Centis R; D'Ambrosio L; Spanevello A; Migliori GB;
Eur Respir J; 2013 Jul; 42(1):288-90. PubMed ID: 23813314
[No Abstract] [Full Text] [Related]
4. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
Yew WW; Chang KC; Chau CH
J Antimicrob Chemother; 2009 Nov; 64(5):1119; author reply 1119-20. PubMed ID: 19666903
[No Abstract] [Full Text] [Related]
5. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.
Koh WJ; Shim TS
J Antimicrob Chemother; 2009 Nov; 64(5):1119-20. PubMed ID: 19744986
[No Abstract] [Full Text] [Related]
6. Linezolid for Treating Tuberculosis: A Delicate Balancing Act.
Maartens G; Benson CA
EBioMedicine; 2015 Nov; 2(11):1568-9. PubMed ID: 26870767
[No Abstract] [Full Text] [Related]
7. Treatment of multidrug-resistant and extensively drug-resistant tuberculosis in adolescent patients.
Rodrigues M; Brito M; Villar M; Correia P
Pediatr Infect Dis J; 2014 Jun; 33(6):657-9. PubMed ID: 24642519
[TBL] [Abstract][Full Text] [Related]
8. Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis.
Nam HS; Koh WJ; Kwon OJ; Cho SN; Shim TS
Int J Antimicrob Agents; 2009 Jan; 33(1):92-3. PubMed ID: 18789655
[No Abstract] [Full Text] [Related]
9. Linezolid for extensively drug-resistant tuberculosis.
Cattaneo D; Orlando G; Cordier L
N Engl J Med; 2013 Jan; 368(3):291. PubMed ID: 23323919
[No Abstract] [Full Text] [Related]
10. Linezolid for extensively drug-resistant tuberculosis.
Dhooria S; Agarwal R; Behera D
N Engl J Med; 2013 Jan; 368(3):290-1. PubMed ID: 23323918
[No Abstract] [Full Text] [Related]
11. Linezolid for extensively drug-resistant tuberculosis.
Jaramillo E; Weyer K; Raviglione M
N Engl J Med; 2013 Jan; 368(3):290. PubMed ID: 23323917
[No Abstract] [Full Text] [Related]
12. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
Sotgiu G; Lange C; Richardson MD; Matteelli A; Centis R; Eker B; Guenther G; Spanevello A; Migliori GB;
J Antimicrob Chemother; 2009 Oct; 64(4):879-83; author reply 883-4. PubMed ID: 19651787
[No Abstract] [Full Text] [Related]
13. Linezolid for multidrug-resistant tuberculosis.
Cox H; Ford N; Hughes J; Goemaere E
Lancet Infect Dis; 2013 Jan; 13(1):16. PubMed ID: 23257228
[No Abstract] [Full Text] [Related]
14. Linezolid for multidrug-resistant tuberculosis.
Chang KC; Leung CC; Daley CL
Lancet Infect Dis; 2012 Jul; 12(7):502-3. PubMed ID: 22742623
[No Abstract] [Full Text] [Related]
15. Linezolid for multidrug-resistant tuberculosis - authors' reply.
Chang KC; Leung CC; Daley CL
Lancet Infect Dis; 2013 Jan; 13(1):16-7. PubMed ID: 23257227
[No Abstract] [Full Text] [Related]
16. Meropenem/clavulanate and linezolid treatment for extensively drug-resistant tuberculosis.
Dauby N; Muylle I; Mouchet F; Sergysels R; Payen MC
Pediatr Infect Dis J; 2011 Sep; 30(9):812-3. PubMed ID: 21378593
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of linezolid against clinical isolates of Mycobacterium tuberculosis, including multidrug-resistant and extensively drug-resistant strains from Beijing, China.
Yang C; Lei H; Wang D; Meng X; He J; Tong A; Zhu L; Jiang Y; Dong M
Jpn J Infect Dis; 2012; 65(3):240-2. PubMed ID: 22627306
[TBL] [Abstract][Full Text] [Related]
18. Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis.
Villar M; Sotgiu G; D'Ambrosio L; Raymundo E; Fernandes L; Barbedo J; Diogo N; Lange C; Centis R; Migliori GB
Eur Respir J; 2011 Sep; 38(3):730-3. PubMed ID: 21885418
[No Abstract] [Full Text] [Related]
19. Second-line drug susceptibilities of multidrug-resistant tuberculosis strains isolated in Thailand: an update.
Chaiprasert A; Srimuang S; Tingtoy N; Makhao N; Sirirudeeporn P; Tomnongdee N; Theankeaw O; Charoensook S; Leechawengwongs M; Prammananan T
Int J Tuberc Lung Dis; 2014 Aug; 18(8):961-3. PubMed ID: 25199012
[TBL] [Abstract][Full Text] [Related]
20. Treatment of extensively drug-resistant tuberculosis.
Aggarwal D; Mohapatra PR; Janmeja AK
Lancet; 2009 Jan; 373(9657):26-7; author reply 27-8. PubMed ID: 19121714
[No Abstract] [Full Text] [Related]
[Next] [New Search]
